Desogestrel and Ethinyl Estradiol Tablets for Birth Control

"Desogestrel and Ethinyl Estradiol Tablets is traditionally used to alleviate symptoms of menopause. Additionally, it can be prescribed for contraception, acne vulgaris prevention, or patient desires oral contraception as birth control methods."

"Affirmative. As per the clinicaltrials.gov listing, this investigation is currently recruiting participants; it was originally posted on September 10th 2021 and its most recent update was March 8th 2022. The study requires 20 people to be signed up from a single medical facility."

"Currently, 15 clinical trials are taking place to investigate Desogestrel and Ethinyl Estradiol Tablets with 3 of these studies at Phase 3. The bulk of the research is being carried out in Savannah however there are 19 sites nationally conducting investigations into this medication."

"Eligible candidates for this study must be of reproductive age and use contraception. Additionally, the desired patient pool is 20 individuals that are between 18 to 45 years old."

"Affirmative. According to clinicaltrials.gov, the study posted on September 10th 2021 is currently recruiting patients and requires 20 participants at a single site. The trial was last updated on March 8th 2022."

"We have assessed the safety of Desogestrel and Ethinyl Estradiol Tablets to be a 3 due its Phase 4 status, which is indicative of approval for medical use."

"The present clinical trial has set the minimum age limit at 18, and a maximum of 45. For those under 18 or over 65, there are 27 and 19 trials respectively which may be suitable for their needs."